clinical stage life sciences venture capital investor

advisors

The Scientific and Medical Advisory Board is composed of highly respected members of the medical scientific community that provide a broad perspective on medical and scientific developments, in-depth expertise in their areas of specialization and extensive networks throughout the medical and scientific community.

 

Stanley N. Cohen, MD

Dr. Cohen is Professor of Genetics and the Kwoh-Ting Li Professor in the School of Medicine at Stanford University. Dr. Cohen is a leading expert in the fields of genetics, molecular biology, biochemistry and microbiology. He co-discovered the methods to transplant and clone DNA (recombinant DNA) which led to the birth of genetic engineering and launched the biotechnology industry. His current investigations include studies of the role of host cell genes in microbial infections. Dr. Cohen is the recipient of many honors including the National Medal of Science, the National Medal of Technology, the Lasker Award for Basic Medical Research, the Wolf Prize in Medicine, the Lemelson-MIT Prize, the Albany Medical Center Prize in Biomedical Research, and the Shaw Prize. He is a member of the U.S. National Academy of Sciences, the National Inventors Hall of Fame, and the Institute of Medicine of the National Academies.

 

Stuart B. Goodman, MD, PhD

Dr. Goodman is a professor in the Division of Orthopaedic Surgery at Stanford University’s School of Medicine. Dr. Goodman specializes in orthopedic surgery with a special focus on arthritis surgery of the lower extremity, joint replacement and revision joint replacement of the hip and knee. His current research examines ways to improve adult reconstructive surgery including total joint replacement procedures, osteotomies, prosthesis design, the effects of mechanical stimulation on tissue differentiation, and the biological aspect of the interface between bone and orthopedic implants and biomaterials. Dr. Goodman is the author of numerous medical journal and orthopedic textbook articles and sits on the editorial board of several medical and biomaterial publications. He was previously elected President of the Society for Biomaterials. He is also a member of several professional organizations including the American Academy of Orthopaedic Surgeons, the Orthopaedic Research Society and the Association of Bone and Joint Surgeons.

 

Yuet W. Kan, MD

Dr. Kan is the Louis K. Diamond Professor of Hematology and chief of the Division of Molecular Medicine and Diagnostics at the University of California, San Francisco. He is an internationally recognized researcher in the field of human genetics. He discovered DNA polymorphism, which is now extensively used for genetic analysis and was the first to establish that a single DNA mutation could result in a human disease. His research is currently focused on the use of gene therapy to treat sickle cell anemia and thalassemia. Dr. Kan is the recipient of many honors including the Shaw Prize in Life Science and Medicine, the Albert Lasker Clinical Medical Research Award, the Helmut Horten Research Award, the American College of Physicians Award, the Waterford Award in Biomedical Sciences, the Allan Award of the American Society of Human Genetics, the Gairdner International Award and the Dameshek Award from the American Society of Hematology. Dr. Kan also serves on the Committee on Human Rights and the Executive Council of the National Academy of Sciences and is a fellow of the Royal Society (London), a member of the Academia Sinica (Taiwan), and a foreign member of the Chinese Academy of Sciences (Beijing). In the past, he has served as president of the American Society of Hematology and was a member of the President’s Committee on the National Medal of Science.

 

James H. Liu, MD

Dr. Liu is chair of the Department of Obstetrics and Gynecology at the University Hospitals MacDonald Women’s Hospital and professor and chair of the Department of Reproductive Biology at Case Western Reserve School of Medicine. Dr. Liu is nationally recognized in the field of reproductive endocrinology and infertility and was named one of The Best Doctors in America. He is subspecialty trained and board certified in the evaluation of endocrinologic diseases ranging from abnormal puberty to disorders of normal reproduction (infertility, endometriosis, PMS, amenorrhea, polycystic ovarian disease) to the natural process of menopause. He has expertise in the medical treatment of menopause, endometriosis, uterine fibroids, and ovulation induction. He is also an expert in microsurgery, hysteroscopy, as well as operative and laser laparoscopy. Dr. Liu serves on multiple committees in the American College of Obstetrics and Gynecology, and he is on the editorial boards of the Clinical Journal of Women’s Health and the Journal of the Society for Gynecologic Investigation. Dr. Liu has published over 100 peer-reviewed articles and chapters.

 

Jerrold M. Olefsky, MD

Dr. Olefsky is Professor of Medicine at the University of California, San Diego (UCSD) Division of Endocrinology and Metabolism and the Associate Dean of Scientific Affairs for the UCSD School of Medicine. One of Dr. Olefsky’s seminal contributions to the field of medicine has been the identification of the role of insulin resistance as a primary cause of Type II (non-insulin dependent, adult-onset) diabetes, polycystic ovarian syndrome and other human diseases. Dr. Olefsky’s research focuses on the molecular mechanisms of insulin and growth factor action in a variety of cell types, with particular emphasis on the insulin signaling pathway leading to stimulation of glucose transport. He has helped define the basic genetic and cellular mechanisms underlying decreased insulin action in human pathophysiologic states. Dr. Olefsky is a member of the Institute of Medicine and was the 1998 recipient of the American Diabetes Association’s Banting Medal for Scientific Achievement.